Consistently, glutamine depletion or the treatment with the glutaminase inhibitor CB-839 significantly suppresses cell proliferation and increases apoptosis in AGC1 KO CRC cell lines compared to wild-type controls [126]. The gene discussed is SLC25A12; the disease is colorectal carcinoma.